Back to Search
Start Over
DIALCAT: Diabetes as an accelerator of cognitive impairment and Alzheimer's disease, comprehensive approach and adherence to treatment
- Source :
- Recercat. Dipósit de la Recerca de Catalunya, instname, UPCommons. Portal del coneixement obert de la UPC, Universitat Politècnica de Catalunya (UPC)
-
Abstract
- In this article, we present the designof an mHealth system to support senior citizens with chronic diseases in managing their adherenceto pharmacological treatment. The DIALCAT system consisting of a smart pill dispenser and a mobile application will be tested in a clinical study for 18 months by patients suffering diabetes with mild cognitive impairment. The clinical trial aims to study the effectof diabetes as an accelerator of cognitive impairment and Alzheimer’s disease and the impact of adherenceto treatment. DIALCAT is a RIS3CAT project co-fundedunder the European ERDF programme.
- Subjects :
- medicine.medical_specialty
General Computer Science
Active and assisted living
Disease
030226 pharmacology & pharmacy
Pharmacological treatment
03 medical and health sciences
0302 clinical medicine
Observància terapeútica
Diabetes mellitus
eHealth
medicine
Treatment adherence
030212 general & internal medicine
Intensive care medicine
Cognitive impairment
mHealth
Medication adherence
business.industry
Enginyeria biomèdica [Àrees temàtiques de la UPC]
Diabetes
Mild cognitive impairment
medicine.disease
Clinical trial
Pill
business
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Recercat. Dipósit de la Recerca de Catalunya, instname, UPCommons. Portal del coneixement obert de la UPC, Universitat Politècnica de Catalunya (UPC)
- Accession number :
- edsair.doi.dedup.....1a76348bf1a1834fd1862586ef4e8b28